Aqupharm 1 (9 mg/ml) Solution for Injection/Infusion

Valsts: Lielbritānija

Valoda: angļu

Klimata pārmaiņas: VMD (Veterinary Medicines Directorate)

Aktīvā sastāvdaļa:

Sodium Chloride

Pieejams no:

Animalcare Ltd

ATĶ kods:

QB05BB01

SNN (starptautisko nepatentēto nosaukumu):

Sodium Chloride

Zāļu forma:

Solution for infusion

Receptes veids:

POM-V - Prescription Only Medicine – Veterinarian

Ārstniecības grupa:

Cats, Cattle, Dogs, Goats, Horses, Pigs, Rabbits, Sheep

Ārstniecības joma:

Replacement Agent

Autorizācija statuss:

Authorized

Autorizācija datums:

2016-09-22

Produkta apraksts

Revised: August 2022
AN: 01024/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Aqupharm 1 (9 mg/ml) solution for injection/infusion
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Sodium Chloride
9 mg
The solution provides
Sodium: 150 mmol/litre
Chloride: 150 mmol/litre
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection/infusion.
Clear, colourless particle free solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, horses, sheep, goats, pigs, dogs, cats and rabbits.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Correction of water: sodium imbalances.
Treatment of metabolic alkalosis.
Rehydration in disease conditions which result in excessive loss of
water and sodium
chloride, and during and after surgery.
Vehicle solution for the administration of other compatible drugs.
4.3
CONTRAINDICATIONS
Do not use in cases of:
-
sodium and water retention (due to cardiac, hepatic or renal failure,
or
enteropathy)
-
hypernatraemia
-
hyperchloraemia
-
hyperhydration.
Revised: August 2022
AN: 01024/2022
Page 2 of 6
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Maintain aseptic precautions.
Use with caution in animals with cardiac or renal impairment as sodium
overload may
occur.
It
should
be
noted
that
sodium
excretion
may
be
impaired
post-
surgery/trauma.
Use with caution in animals with hypokalaemia.
Serum electrolyte levels, water and acid-base balance and the clinical
condition of
the animal should be closely monitored during the treatment in order
to prevent
overdose, particularly in cases of renal or metabolic changes.
A risk of thrombosis with intravenous infusion should be considered.
This product should not be used for longer than is necessary to
correct and sustain
circulating volume. Inappropriate/excessive use may worsen or create a
metabolic
acidosis.
This product does not contain an antim